$TDOC

Rodrigues Fernando M. sold $71K of TDOC

Rodrigues Fernando M. (President of BetterHelp) sold 9,572 shares of Teladoc Health, Inc. (TDOC) at $7.40 on 2026-06-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Rodrigues Fernando M.
Published Jun 4, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 8:12 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$TDOC
Neutral
medium confidence
Mentioned
$TDOC
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TDOCNeutralLow
01

Why it matters

The disclosure provides a datapoint on insider activity but does not introduce new company fundamentals; interpretive value is reduced by the stated pre-arranged 10b5-1 plan.

02

Market read

Traders may briefly reassess sentiment/positioning around TDOC due to disclosed insider selling, but the scheduled nature limits conviction.

03

What to watch

Insider selling volume alone is not a reliable predictor; traders should compare with prior Form 4 patterns and any concurrent company-specific news (earnings, guidance, litigation).

Relevance 6/10Novelty 3/10Timing: Filed after-hours (2026-06-04 16:05 ET) for a sale executed 2026-06-03

Background

This is an SEC Form 4 insider transaction disclosure for Teladoc Health, Inc. (TDOC).

Company-level read

Ticker impact

$TDOCNeutralMedium confidence
Context

SEC Form 4 shows TDOC officer Rodrigues Fernando M. sold 9,572 shares in an open-market transaction under a 10b5-1 plan.

Expected impact

Small, short-lived negative bias possible; no clear directional catalyst beyond disclosure.

Evidence & confidence

The filing is a routine insider transaction and explicitly tied to a pre-arranged 10b5-1 plan, reducing interpretive value versus discretionary selling.

Market effects

Minimal; single-company insider sale with no sector-wide catalyst.

None.

None.

Counterpoint

Because the sale is under a 10b5-1 plan and the position is fully exited, it may reflect scheduled liquidity rather than bearish expectations.

Key entities

  • Teladoc Health, Inc.

    Subject of the Form 4 insider transaction; officer sold shares under a 10b5-1 plan.

  • Rodrigues Fernando M.

    President of BetterHelp; reported as an officer of the issuer for Form 4 purposes.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$TDOCLow

Teladoc nabs insurance veteran as new CFO

Teladoc Health appointed Michael Grasher as its new CFO, effective immediately. Grasher succeeds Mala Murthy, who left in November. He brings over 30 years of experience in insurance and financial services, most recently as CFO of IFG Companies. The move follows Teladoc's recent revenue guidance reduction, partly due to challenges in its mental health unit, BetterHelp.

$TDOCMed

Teladoc appoints insurance executive Michael Grasher as CFO

Teladoc Health named Michael Grasher as its new CFO. Grasher, with over 30 years of experience in insurance, previously served as CFO of IFG Companies. The appointment follows Teladoc's recent revenue forecast cut and challenges in its mental health unit, BetterHelp. Analyst Elizabeth Anderson views the move positively for Teladoc's leadership.

$TDOCMedAI 8/10

Teladoc Health (TDOC) Q2 2026 Earnings Call Transcript

Teladoc Health (TDOC) reported Q2 2026 revenue of $606.9 million, down 4% year over year, with BetterHelp revenue $212.6 million, down 11% due to a faster shift from cash pay to insurance. Adjusted EBITDA was $65.7 million. Full-year 2026 guidance: revenue $2.36B to $2.45B and adjusted EBITDA $271M to $303M. CEO Charles Divita said insurance demand outpaced provider capacity.